Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hemangioma × Therapeutics × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 9 Fatigue 8 Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Hodgkin Disease 4 Congenital Abnormalities 4 Colorectal Neoplasms 4 Sleep Wake Disorders 3 Sezary Syndrome 3 Sexual Dysfunction, Physiological 3 Sarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Prolymphocytic 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Leukemia, Mast-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Large Granular Lymphocytic 3 Leukemia, Hairy Cell 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3

Interventions

Urine Specimen Collection 1 Therapeutics 1 Steroids 1 Propranolol 1 Prednisolone 1 Observation 1 High-Energy Shock Waves 1 Hepatectomy 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866827 2019-01-11

Airway Vascular Lesions

University of Arkansas

Hemangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡